Over the past 12 months, 0 insiders at ALBIREO PHARMA, INC. filed 0 open-market SEC Form 4 transactions on ALBO: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 23, 23 | Martha J. CarterChief Regulatory Officer | SELL | 120 | $43.80 | $5K |
| Jan 23, 23 | Cooper Ronald Harold WilfredPresident and CEO | SELL | 1.1K | $43.80 | $46K |
| Jan 23, 23 | Jason DuncanChief Legal Officer and GC | SELL | 228 | $43.80 | $10K |
| Jan 23, 23 | Michelle GrahamChief Human Resources Officer | SELL | 102 | $43.80 | $4K |
| Jan 23, 23 | Simon N.r. HarfordCFO and Treasurer | SELL | 102 | $43.80 | $4K |
| Jan 23, 23 | Jan MattssonChief Scientific Officer | SELL | 197 | $43.80 | $9K |
| Jan 23, 23 | Pamela StephensonChief Commercial Officer | SELL | 102 | $43.80 | $4K |
| Jan 19, 23 | Martha J. CarterChief Regulatory Officer | SELL | 938 | $43.90 | $41K |
| Jan 19, 23 | Jason DuncanChief Legal Officer and GC | SELL | 938 | $43.90 | $41K |
| Jan 19, 23 | Michelle GrahamChief Human Resources Officer | SELL | 1.8K | $43.90 | $78K |
| Jan 19, 23 | Simon N.r. HarfordCFO and Treasurer | SELL | 1.8K | $43.80 | $78K |
| Jan 19, 23 | Jan MattssonChief Scientific Officer | SELL | 3.1K | $43.80 | $135K |
| Jan 19, 23 | Pamela StephensonChief Commercial Officer | SELL | 1.8K | $43.90 | $78K |
| Dec 27, 22 | Pamela StephensonChief Commercial Officer | SELL | 469 | $19.06 | $9K |
| Oct 24, 22 | Martha J. CarterChief Regulatory Officer | SELL | 104 | $19.58 | $2K |
| Oct 24, 22 | Cooper Ronald Harold WilfredPresident and CEO | SELL | 919 | $19.58 | $18K |
| Oct 24, 22 | Jason DuncanChief Legal Officer and GC | SELL | 456 | $19.58 | $9K |
| Oct 24, 22 | Michelle GrahamChief Human Resources Officer | SELL | 104 | $19.58 | $2K |
| Oct 24, 22 | Simon N.r. HarfordCFO and Treasurer | SELL | 104 | $19.58 | $2K |
| Oct 24, 22 | Jan MattssonChief Scientific Officer | SELL | 202 | $19.58 | $4K |
| Oct 24, 22 | Pamela StephensonChief Commercial Officer | SELL | 104 | $19.58 | $2K |
| Oct 13, 22 | Perceptive Advisors LlcTenPercentOwner | SELL | 178.7K | $22.79 | $3.9M |
| Oct 12, 22 | Perceptive Advisors LlcTenPercentOwner | SELL | 90.0K | $23.23 | $2.0M |
| Oct 11, 22 | Simon N.r. HarfordCFO and Treasurer | SELL | 80 | $23.79 | $2K |
| Oct 11, 22 | Perceptive Advisors LlcTenPercentOwner | SELL | 100.3K | $24.78 | $2.3M |
| Sep 26, 22 | Pamela StephensonChief Commercial Officer | SELL | 445 | $19.40 | $9K |
| Jul 25, 22 | Jason DuncanChief Legal Officer and GC | SELL | 220 | $24.40 | $5K |
| Jul 22, 22 | Martha J. CarterChief Regulatory Officer | SELL | 106 | $24.68 | $3K |
| Jul 22, 22 | Cooper Ronald Harold WilfredPresident and CEO | SELL | 929 | $24.67 | $23K |
| Jul 22, 22 | Jason DuncanChief Legal Officer and GC | SELL | 238 | $24.68 | $6K |
| Jul 22, 22 | Michelle GrahamChief Human Resources Officer | SELL | 106 | $24.67 | $3K |
| Jul 22, 22 | Simon N.r. HarfordCFO and Treasurer | SELL | 106 | $24.67 | $3K |
| Jul 22, 22 | Jan MattssonChief Scientific Officer | SELL | 205 | $24.68 | $5K |
| Jul 22, 22 | Pamela StephensonChief Commercial Officer | SELL | 106 | $24.67 | $3K |
| Jul 12, 22 | Simon N.r. HarfordCFO and Treasurer | SELL | 95 | $24.03 | $2K |
| Jun 27, 22 | Pamela StephensonChief Commercial Officer | SELL | 461 | $19.47 | $9K |
| Apr 25, 22 | Jason DuncanChief Legal Officer and GC | SELL | 221 | $33.44 | $7K |
| Apr 22, 22 | Martha J. CarterChief Regulatory Officer | SELL | 103 | $32.92 | $3K |
| Apr 22, 22 | Cooper Ronald Harold WilfredPresident and CEO | SELL | 907 | $33.11 | $30K |
| Apr 22, 22 | Jason DuncanChief Legal Officer and GC | SELL | 240 | $33.07 | $8K |
| Apr 22, 22 | Michelle GrahamChief Human Resources Officer | SELL | 103 | $32.92 | $3K |
| Apr 22, 22 | Simon N.r. HarfordCFO and Treasurer | SELL | 103 | $32.92 | $3K |
| Apr 22, 22 | Jan MattssonChief Scientific Officer | SELL | 200 | $32.92 | $7K |
| Apr 22, 22 | Pamela StephensonChief Commercial Officer | SELL | 103 | $32.92 | $3K |
| Apr 11, 22 | Simon N.r. HarfordCFO and Treasurer | SELL | 96 | $35.74 | $3K |
| Mar 28, 22 | Pamela StephensonChief Commercial Officer | SELL | 454 | $30.53 | $14K |
| Jan 24, 22 | Martha J. CarterChief Regulatory Officer | SELL | 423 | $24.52 | $10K |
| Jan 24, 22 | Cooper Ronald Harold WilfredPresident and CEO | SELL | 3.7K | $24.88 | $92K |
| Jan 24, 22 | Jason DuncanChief Legal Officer and GC | SELL | 1.2K | $25.09 | $29K |
| Jan 24, 22 | Michelle GrahamChief Human Resources Officer | SELL | 418 | $24.72 | $10K |
Over the past 12 months, insiders at ALBIREO PHARMA, INC. filed 0 open-market purchases worth $0 and 0 sales worth $0 on ALBO, which makes them mixed over the period. The most recent Form 4 was filed on .
0 different insiders at ALBIREO PHARMA, INC. filed open-market SEC Form 4 transactions on ALBO over the last 12 months.
InsiderTape plots every ALBO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ALBIREO PHARMA, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →